8/8/2023 0 Comments Boom 3d microscope![]() Omax products are warrantied against manufacturer’s defects in material and workmanship from the original date of purchase, for the following years: Of universal double-arm boom stand with rack Stand provide extra working space and secure (54mm~75mm) adjustable interpupillary distanceĮrect images over a super wide field viewīoom stand allowing point microscope head inĪnd 3D boom stand with adjustable body angles (33mm) super widefield of view and 4-1/4" ![]() High eyepoint widefield eyepieces with diopter Widefield continuous stereo zoom magnification Images through eyepieces and trinocular port Optical system for simultaneously observing The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines. On the date of publication, Alex Sirois did not have (either directly or indirectly) any positions in the securities mentioned in this article. On the valuation front, ZYME stock is trading at 3.4 times earnings and 1.3 times sales, which is better than 94% and 93% of the industry, respectively. That’s up 75% on a year-over-year basis and would be a quadrupling of revenue in three years. And 2024 sales are expected to hit $116.3 million. While sales are expected to decline to $66.6 million this year, that’s still up nearly 150% from 2021. The company will also receive royalties related to that sale. The reason for the revenue spike was a one-time $325 million payment by Jazz Pharmaceuticals (NASDAQ: JAZZ) to develop Zymeworks’ cancer drug zanidatamab. In 2022, revenue increased more than 15-fold to $412.5 million. In 2021, Zymeworks generated $26.7 million in revenue. The stock is volatile, trading in a range between $4.11 and $10.80 per share over the past year. Shares are up 10% year to date and 22% over the past 12 months. Zymeworks (NASDAQ: ZYME) is a clinical-stage biopharmaceutical company. If chip packaging and testing firms get a bit of the limelight, shares could pop. ![]() Its forward P/E of 13.5% is better than 84% of its peers, while its P/S ratio of 0.8% is better than nearly 88% of the industry. ![]() Further, ASE’s three-year revenue growth rate of 17% is better than 64% of the industry.įurthermore, shares look extremely undervalued based on multiple metrics. While analysts are predicting a decline in ASE Technology Holdings’ revenue and earnings this year, they are forecasting increases of 10.5% and 34%, respectively, in 2024. Despite its sub-$10 share price, th e stock is a less-volatile choice than some other big-name chip stocks that face boom-or-bust cyclical trends. Shares are up 28.5% this year to trade around $8. Instead, ASE Technology Holdings packages and tests circuits. Nor does it design chips and outsource their production like Nvidia (NASDAQ: NVDA). It isn’t a foundry like Taiwan Semiconductor Manufacturing (NYSE: TSM), though. While the stock is not widely covered by analysts, of the five who do, four rate it a “buy” with an average price target of $6.37, implying upside of nearly 400%.ĪSE Technology Holdings (NYSE: ASX) is a Taiwan-based chip firm. LLAP has a three-year revenue growth rate of 63.4%, better than 96% of the industry, and is trading at 1.7 times sales, which is better than 51% of its peers. Space Force’s Space Development Agency in an agreement valued at approximately $700 million. Earlier in 2022, Lockheed selected Terran Orbital to produce 42 satellites for the U.S. In late 2022, Lockheed Martin upped its total equity stake from 9.4% to 33.5% with a $100 million investment in Terran Orbital. defense contractor Lockheed Martin (NYSE: LMT) has taken a massive stake in the company. Terran Orbital began receiving milestone payments in connection with that deal in April.Īdditionally, leading U.S. Although shares did surge more than 70% in a single day in February after the company announced a $2.4 billion deal with Rivada Space Networks to build 300 satellites for the wireless communications company. While the stock has been beaten up, it holds immense promise, and not just because a small move in the stock price can result in a large percentage gain. Today, it has a market cap of around $186 million and a share price of just $1.28. Florida-based space-tech company Terran Orbital (NYSE: LLAP) makes small satellites for the aerospace and defense industries. The stock has struggled since going public via a special purpose acquisition company ( SPAC) merger in October 2021 that valued the company at $1.8 billion.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |